Nonviral Vector-Borne Zoonoses Associated with Mammals in the United States

1995 ◽  
Vol 76 (3) ◽  
pp. 695 ◽  
Author(s):  
Kenneth L. Gage ◽  
Richard S. Ostfeld ◽  
James G. Olson
Keyword(s):  
United States ◽  
The United States ◽  
Nonviral Vector ◽  
Vector Borne

scholarly journals Advancing the Science of Tick and Tick-Borne Disease Surveillance in the United States

Insects ◽  
2019 ◽  
Vol 10 (10) ◽  
pp. 361 ◽  
Author(s):  
Samantha Wisely ◽  
Gregory Glass
Keyword(s):  
Public Health ◽  
United States ◽  
Workforce Development ◽  
Disease Surveillance ◽  
The United States ◽  
Centers Of Excellence ◽  
Public Health Burden ◽  
Vector Borne Disease ◽  
Tick Borne Disease ◽  
Vector Borne

Globally, vector-borne diseases are an increasing public health burden; in the United States, tick-borne diseases have tripled in the last three years. The United States Centers for Disease Control and Prevention (CDC) recognizes the need for resilience to the increasing vector-borne disease burden and has called for increased partnerships and sustained networks to identify and respond to the most pressing challenges that face vector-borne disease management, including increased surveillance. To increase applied research, develop communities of practice, and enhance workforce development, the CDC has created five regional Centers of Excellence in Vector-borne Disease. These Centers are a partnership of public health agencies, vector control groups, academic institutions, and industries. This special issue on tick and tick-borne disease surveillance is a collection of research articles on multiple aspects of surveillance from authors that are affiliated with or funded by the CDC Centers of Excellence. This body of work illustrates a community-based system of research by which participants share common problems and use integrated methodologies to produce outputs and effect outcomes that benefit human, animal and environmental health.

scholarly journals Projected expansion in climatic suitability for Trypanosoma cruzi, the etiological agent of Chagas Disease, and five widespread Triatoma species by 2070: the role of climate change on infectious diseases

2018 ◽  
Author(s):  
Matthew Nichols ◽  
Chris J Butler ◽  
Wayne D Lord ◽  
Michelle L Haynie
Keyword(s):  
Climate Change ◽  
United States ◽  
Trypanosoma Cruzi ◽  
Disease Surveillance ◽  
Gastrointestinal Diseases ◽  
The United States ◽  
Climatic Conditions ◽  
Vector Borne ◽  
Current Potential

The vector-borne parasite Trypanosoma cruzi infects seven million individuals globally and causes chronic cardiomyopathy and gastrointestinal diseases. Recently, T. cruzi has emerged in the southern United States. It is crucial for disease surveillance efforts to detail regions that present favorable climatic conditions for T. cruzi and vector establishment. We used MaxEnt to develop an ecological niche model for T. cruzi and five widespread Triatoma vectors based on 546 published localities within the United States. We modeled regions of current potential T. cruzi and Triatoma distribution and then regions projected to have suitable climatic conditions by 2070. Regions with suitable climatic conditions for the study organisms are predicted to increase within the United States. Our findings agree with the hypothesis that climate change will facilitate the expansion of tropical diseases throughout temperate regions and suggest climate change will influence the expansion of T. cruzi and Triatoma vectors in the United States.

scholarly journals Recent Progress in Lyme Disease and Remaining Challenges

2021 ◽  
Vol 8 ◽  
Author(s):  
Jason R. Bobe ◽  
Brandon L. Jutras ◽  
Elizabeth J. Horn ◽  
Monica E. Embers ◽  
Allison Bailey ◽  
...  
Keyword(s):  
United States ◽  
Lyme Disease ◽  
Molecular Mechanisms ◽  
The United States ◽  
Persistent Symptoms ◽  
Number Of Patients ◽  
Vector Borne ◽  
The Many ◽  
Long Term Impact ◽  
Patients Experience

Lyme disease (also known as Lyme borreliosis) is the most common vector-borne disease in the United States with an estimated 476,000 cases per year. While historically, the long-term impact of Lyme disease on patients has been controversial, mounting evidence supports the idea that a substantial number of patients experience persistent symptoms following treatment. The research community has largely lacked the necessary funding to properly advance the scientific and clinical understanding of the disease, or to develop and evaluate innovative approaches for prevention, diagnosis, and treatment. Given the many outstanding questions raised into the diagnosis, clinical presentation and treatment of Lyme disease, and the underlying molecular mechanisms that trigger persistent disease, there is an urgent need for more support. This review article summarizes progress over the past 5 years in our understanding of Lyme and tick-borne diseases in the United States and highlights remaining challenges.

Association Between Exposure to Ehrlichia spp. and Risk of Developing Chronic Kidney Disease in Dogs

2020 ◽  
Vol 56 (3) ◽  
pp. 159-164 ◽  
Author(s):  
Wade Burton ◽  
Corie Drake ◽  
Jennifer Ogeer ◽  
Jesse Buch ◽  
Rebekah Mack ◽  
...  
Keyword(s):  
United States ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
The United States ◽  
Urine Specific Gravity ◽  
Matched Cohort ◽  
Patient History ◽  
Symmetric Dimethylarginine ◽  
Vector Borne ◽  
Incidence Of Ckd

ABSTRACT Ehrlichiosis is a common vector-borne disease caused by Ehrlichia spp. This retrospective matched cohort study was performed to determine if dogs with Ehrlichia spp. antibodies had an increased incidence of chronic kidney disease (CKD). Exposure to Ehrlichia spp. was defined as having an Ehrlichia spp. antibody–positive result recorded at any point in their available patient history. The outcome of CKD was defined as concurrent increased symmetric dimethylarginine (>14 µg/dL) and creatinine (>1.5 mg/dL) for a minimum of 25 days with inappropriate urine specific gravity (<1.030). Patients were matched using propensity score matching to control for age, geography, and breed. A total of 22,440 patients and controls in E canis–endemic regions of the United States were used in this analysis. Contingency tables were used to compare dogs with and without exposure to Ehrlichia spp.–infected ticks and CKD outcome. The relative risk of CKD for patients exposed to ticks carrying Ehrlichia spp. was found to be 2.12 (95% confidence interval [1.35–3.15], p < 0.0006). This study identified that testing positive for Ehrlichia spp. antibodies in E canis–endemic regions is associated with higher incidence of CKD in dogs.

scholarly journals Kissing Bugs in the United States: Risk for Vector-Borne Disease in Humans

2014 ◽  
Vol 8s2 ◽  
pp. EHI.S16003 ◽  
Author(s):  
Stephen A. Klotz ◽  
Patricia L. Dorn ◽  
Mark Mosbacher ◽  
Justin O. Schmidt
Keyword(s):  
United States ◽  
The United States ◽  
Vector Borne Disease ◽  
Vector Borne
Sign in / Sign up

Export Citation Format

Share Document